Tags

Type your tag names separated by a space and hit enter

Epidemiology of hepatitis E virus in Iran.
World J Gastroenterol. 2016 Jun 14; 22(22):5143-53.WJ

Abstract

Iran is known as an endemic country for hepatitis E virus (HEV) infection, while there are variations in the epidemiology of HEV infection throughout the country. The available epidemiological studies in different regions of Iran show HEV seroprevalence of 1.1%-14.2% among general population, 4.5% -14.3% among blood donors, 6.1%-22.8% among injecting drug users, 6.3%-28.3% among hemodialysis patients, 1.6%-11.3% among patients infected with other hepatitis viruses, 27.5% among patients with chronic liver disease, 30.8% among kidney transplant recipient patients, and 10%-16.4% among human immunodeficiency virus-infected patients. These variations reflect differences in the status of public health and hygiene, risk factors, and routes of transmission in different regions and groups. Therefore, it is necessary to review the epidemiology of HEV infection to determine the most prevalent risk factors and routes of transmission, and to evaluate the effectiveness of preventive strategies employed in the public health services of the country. Moreover, the other epidemiological aspects of HEV, including the genotypic pattern, extra hepatic manifestations, and incidence of chronic infection need to be investigated among Iranian population to expand the current knowledge on the epidemiology of HEV and to clarify the real burden of HEV infection. Therefore, this review was performed to provide a general overview regarding the epidemiology of HEV in Iran.

Authors+Show Affiliations

Reza Taherkhani, Fatemeh Farshadpour, Department of Microbiology and Parasitology, School of Medicine, Bushehr University of Medical Sciences, Bushehr 7514633341, Iran.Reza Taherkhani, Fatemeh Farshadpour, Department of Microbiology and Parasitology, School of Medicine, Bushehr University of Medical Sciences, Bushehr 7514633341, Iran.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

27298557

Citation

Taherkhani, Reza, and Fatemeh Farshadpour. "Epidemiology of Hepatitis E Virus in Iran." World Journal of Gastroenterology, vol. 22, no. 22, 2016, pp. 5143-53.
Taherkhani R, Farshadpour F. Epidemiology of hepatitis E virus in Iran. World J Gastroenterol. 2016;22(22):5143-53.
Taherkhani, R., & Farshadpour, F. (2016). Epidemiology of hepatitis E virus in Iran. World Journal of Gastroenterology, 22(22), 5143-53. https://doi.org/10.3748/wjg.v22.i22.5143
Taherkhani R, Farshadpour F. Epidemiology of Hepatitis E Virus in Iran. World J Gastroenterol. 2016 Jun 14;22(22):5143-53. PubMed PMID: 27298557.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Epidemiology of hepatitis E virus in Iran. AU - Taherkhani,Reza, AU - Farshadpour,Fatemeh, PY - 2016/03/22/received PY - 2016/04/22/revised PY - 2016/05/04/accepted PY - 2016/6/15/entrez PY - 2016/6/15/pubmed PY - 2017/4/11/medline KW - Blood donors KW - Chronic liver disease KW - Epidemiology KW - General population KW - Hemodialysis KW - Hepatitis E virus KW - Immunocompromised patients KW - Injecting drug users KW - Iran KW - Prevalence SP - 5143 EP - 53 JF - World journal of gastroenterology JO - World J Gastroenterol VL - 22 IS - 22 N2 - Iran is known as an endemic country for hepatitis E virus (HEV) infection, while there are variations in the epidemiology of HEV infection throughout the country. The available epidemiological studies in different regions of Iran show HEV seroprevalence of 1.1%-14.2% among general population, 4.5% -14.3% among blood donors, 6.1%-22.8% among injecting drug users, 6.3%-28.3% among hemodialysis patients, 1.6%-11.3% among patients infected with other hepatitis viruses, 27.5% among patients with chronic liver disease, 30.8% among kidney transplant recipient patients, and 10%-16.4% among human immunodeficiency virus-infected patients. These variations reflect differences in the status of public health and hygiene, risk factors, and routes of transmission in different regions and groups. Therefore, it is necessary to review the epidemiology of HEV infection to determine the most prevalent risk factors and routes of transmission, and to evaluate the effectiveness of preventive strategies employed in the public health services of the country. Moreover, the other epidemiological aspects of HEV, including the genotypic pattern, extra hepatic manifestations, and incidence of chronic infection need to be investigated among Iranian population to expand the current knowledge on the epidemiology of HEV and to clarify the real burden of HEV infection. Therefore, this review was performed to provide a general overview regarding the epidemiology of HEV in Iran. SN - 2219-2840 UR - https://www.unboundmedicine.com/medline/citation/27298557/Epidemiology_of_hepatitis_E_virus_in_Iran_ L2 - https://www.wjgnet.com/1007-9327/full/v22/i22/5143.htm DB - PRIME DP - Unbound Medicine ER -